This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Martens, P. Articles by Johnsson, P. Search for Related Content PubMed PubMed Citation Articles by Martens, P. Articles by Johnsson, P. Pubmed/NCBI databases Substance via MeSH

(Stroke. 1998;29:2363-2366.)
© 1998 American Heart Association, Inc.

Original Contributions

Serum S-100 and Neuron-Specific Enolase for Prediction of Regaining Consciousness After Global Cerebral Ischemia

Patrick Martens, MD; Andreas Raabe, MD; Per Johnsson, MD, PhD

From the Department of Anesthesia and Critical Care, Algemeen Ziekenhuis St Jan, Brugge, Belgium (P.M.); the Neurosurgical Department, University of Leipzig, Leipzig, Germany (A.R.); and the Centre of Heart and Lung Diseases, Department of Cardiothoracic Surgery, Malmö University Hospital, Malmö, Sweden (P.J.).

Correspondence to Patrick Martens, MD, Department of Anaesthesia and Critical Care, A.Z. St.-Jan, Ruddershove 10, 8000 Brugge, Belgium. E-mail pmartens{at}spoed.azbrugge.be

Background and Purpose—The aim of our study was to assess the use of S-100 protein (S-100) and neuron-specific enolase (NSE) in serum and cerebrospinal fluid (CSF) for the prediction of patients' regaining consciousness after acute global cerebral ischemia.

Methods—Sixty-four unconscious patients were followed until the return of consciousness or until death/vegetative state. Serum and CSF samples for measurement of S-100 and NSE using an immunoradiometric assay technique were obtained 24 hours (serum) and 48 hours (CSF) after the acute event and correlated with patient outcome.

Results—Values for serum S-100 protein, serum NSE, CSF S-100, and CSF NSE were significantly different in the 2 outcome groups. A serum S-100 value of >0.7 µg/L was found to be a predictor of not regaining consciousness, with a high positive predictive value (95%) and high specificity (96%).

Conclusions—S-100 protein used as serum marker 24 hours after acute global cerebral ischemia gives reliable and independent information on the outcome of the patient that is comparable or superior to that obtained with CSF markers. Therefore, S-100 may be a serum marker of brain cell damage useful for clinical assessment of these patients.

Key Words: biological markers • cerebral ischemia, global • heart arrest • nerve tissue protein S-100 • neuron-specific enolase • prognosis

This article has been cited by other articles:

				N. R Grubb, C. Simpson, R. A Sherwood, H. D Abraha, S. M Cobbe, R. E O'Carroll, I. Deary, and K. A A Fox Prediction of cognitive dysfunction after resuscitation from out-of-hospital cardiac arrest using serum neuron-specific enolase and protein S-100 Heart, October 1, 2007; 93(10): 1268 - 1273. [Abstract] [Full Text] [PDF]

				J. Reisinger, K. Hollinger, W. Lang, C. Steiner, T. Winter, E. Zeindlhofer, M. Mori, A. Schiller, A. Lindorfer, K. Wiesinger, et al. Prediction of neurological outcome after cardiopulmonary resuscitation by serial determination of serum neuron-specific enolase Eur. Heart J., January 1, 2007; 28(1): 52 - 58. [Abstract] [Full Text] [PDF]

				E.F.M. Wijdicks, A. Hijdra, G. B. Young, C. L. Bassetti, and S. Wiebe Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, July 25, 2006; 67(2): 203 - 210. [Abstract] [Full Text] [PDF]

				Part 4: Advanced Life Support Circulation, November 29, 2005; 112(22_suppl): III-25 - III-54. [Full Text] [PDF]

				A. Larsson, M. Lipcsey, J. Sjolin, L.-O. Hansson, and M. B. Eriksson Slight Increase of Serum S-100B During Porcine Endotoxemic Shock May Indicate Blood-Brain Barrier Damage Anesth. Analg., November 1, 2005; 101(5): 1465 - 1469. [Abstract] [Full Text] [PDF]

				M. M.A.L. Pelsers, T. Hanhoff, D. Van der Voort, B. Arts, M. Peters, R. Ponds, A. Honig, W. Rudzinski, F. Spener, J. R. de Kruijk, et al. Brain- and Heart-Type Fatty Acid-Binding Proteins in the Brain: Tissue Distribution and Clinical Utility Clin. Chem., September 1, 2004; 50(9): 1568 - 1575. [Abstract] [Full Text] [PDF]

				A. P. Schmidt, A. B.L. Tort, O. B. Amaral, A. P. Schmidt, R. Walz, J. Vettorazzi-Stuckzynski, S. H. Martins-Costa, J. G. L. Ramos, D. O. Souza, and L. V.C. Portela Serum S100B in Pregnancy-Related Hypertensive Disorders: A Case-Control Study Clin. Chem., February 1, 2004; 50(2): 435 - 438. [Full Text] [PDF]

				J. R. Lynch, R. Blessing, W. D. White, H. P. Grocott, M. F. Newman, and D. T. Laskowitz Novel Diagnostic Test for Acute Stroke Stroke, January 1, 2004; 35(1): 57 - 63. [Abstract] [Full Text] [PDF]

				M. A. Reynolds, H. J. Kirchick, J. R. Dahlen, J. M. Anderberg, P. H. McPherson, K. K. Nakamura, D. T. Laskowitz, G. E. Valkirs, and K. F. Buechler Early Biomarkers of Stroke Clin. Chem., October 1, 2003; 49(10): 1733 - 1739. [Abstract] [Full Text] [PDF]

				J de Vries, W A M H Thijssen, S E A Snels, T Menovsky, N G M Peer, and K J B Lamers Intraoperative values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgical patients J. Neurol. Neurosurg. Psychiatry, November 1, 2001; 71(5): 671 - 674. [Abstract] [Full Text] [PDF]

				M. J. A. Robson, R. P. Alston, I. J. Deary, P. J. D. Andrews, and M. J. Souter Jugular Bulb Oxyhemoglobin Desaturation, S100{beta}, and Neurologic and Cognitive Outcomes After Coronary Artery Surgery Anesth. Analg., October 1, 2001; 93(4): 839 - 845. [Abstract] [Full Text] [PDF]

				N. R GRUBB Managing out-of-hospital cardiac arrest survivors: 1. Neurological perspective Heart, January 1, 2001; 85(1): 6 - 8. [Full Text]

				M. Herrmann, P. Vos, M. T. Wunderlich, C. H. M. M. de Bruijn, and K. J. B. Lamers Release of Glial Tissue-Specific Proteins After Acute Stroke : A Comparative Analysis of Serum Concentrations of Protein S-100B and Glial Fibrillary Acidic Protein Stroke, November 1, 2000; 31(11): 2670 - 2677. [Abstract] [Full Text] [PDF]

				M. Herrmann, A. D. Ebert, I. Galazky, M. T. Wunderlich, W. S. Kunz, and C. Huth Neurobehavioral Outcome Prediction After Cardiac Surgery : Role of Neurobiochemical Markers of Damage to Neuronal and Glial Brain Tissue Stroke, March 1, 2000; 31(3): 645 - 650. [Abstract] [Full Text] [PDF]

				W. Schoerkhuber, H. Kittler, F. Sterz, W. Behringer, M. Holzer, M. Frossard, S. Spitzauer, and A. N. Laggner Time Course of Serum Neuron-Specific Enolase : A Predictor of Neurological Outcome in Patients Resuscitated From Cardiac Arrest Stroke, August 1, 1999; 30(8): 1598 - 1603. [Abstract] [Full Text] [PDF]